Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabine/Nab-Paclitaxel
Authors:
Open Access
- 1 January 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 8, 0937
Abstract
Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis. Chemotherapy remains the mainstay for unresectable cases, yet regimens like AG (gemcitabine/nab-paclitaxel) exhibit heterogeneous efficacy. Tumor fibrosis has emerged as a potential predictor of treatment response but lacks validated noninvasive assessment methods. To address this, in this multicenter study, tumor fibrosis was quantified in 361 patients with resectable PDAC from SYSUCC, XYCSU, and TCGA cohorts using deep learning-based tissue segmentation on hematoxylin and eosin-stained whole-slide images. Fibrosis was defined as stromal proportion, and its association with overall survival (OS) was evaluated. Transcriptomic profiling was performed in 51 XYCSU cases to validate the biological relevance of fibrosis quantification. A radiomics model (RM) was then developed using preoperative contrast-enhanced computed tomography (CT) scans from SYSUCC to predict fibrosis and externally validated in XYCSU. Clinical utility was assessed in an independent cohort of 295 unresectable PDAC patients treated with AG, FOLFIRINOX, or SOXIRI. High fibrosis correlated with prolonged OS across resectable cohorts (all P < 0.05). Transcriptomic analysis revealed enrichment of fibrosis-related pathways in high-fibrosis tumors. The RM achieved an area under the curve of 0.718 (95% confidence interval: 0.627 to 0.823) in the external test set. Among patients receiving AG, those with CT-predicted high fibrosis had significantly longer progression-free survival (median: 6.23 versus 4.70 months, P = 0.037) and OS (13.37 versus 7.73 months, P = 0.002). No significant survival benefit was observed for high-fibrosis patients receiving FOLFIRINOX or SOXIRI. CT-based fibrosis quantification offers a robust, noninvasive biomarker for predicting AG efficacy in unresectable PDAC.Keywords
Funding Information
- Guangdong Basic and Applied Basic Research Foundation (No. 2025A1515011821)
- Shenzhen Science and Technology Program (No. JCYJ20240813143302004)
- 2024 Hospital-Level Clinical Research Key Project (20243357014)
- National Natural Science Foundation of China (Nos. 12326619 and 62171290)
- Science and Technology Planning Project of Guangdong Province (No. 2023A0505020002)
- Frontier Technology Development Program of Jiangsu Province (No. BF2024078)
- the Key Research and Development Program of Hunan Province of China (No. 2024JK2111)
This publication has 61 references indexed in Scilit:
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal AdenocarcinomaCancer Cell, 2014
- Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 TrialJNCI: Journal of the National Cancer Institute, 2013
- Stromal disrupting effects of nab-paclitaxel in pancreatic cancerBritish Journal of Cancer, 2013
- Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loopBMC Cancer, 2013
- Solid Pancreatic Lesions: Characterization by Using Timing Bolus Dynamic Contrast-enhanced MR Imaging Assessment—A Preliminary StudyRadiology, 2013
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II TrialJournal of Clinical Oncology, 2011
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic CancerScience, 2009
- Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor ProgressionCancer Research, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005